Treatment of advanced solid tumors with immunotoxin LMB-1: An antibody linked to Pseudomonas exotoxin

Nature Medicine

Volumn 2, Issue 3, 1996, Pages 350-353

  Pai, Lee H ^a   Wittes, Robert ^a   Setser, Ann ^a   Willingham, Mark C ^b   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; LMB 1; MONOCLONAL ANTIBODY; PSEUDOMONAS EXOTOXIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COLON CANCER; FEMALE; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; DRUG TOLERANCE; EXOTOXINS; FEMALE; HUMANS; IMMUNOTOXINS; LEWIS BLOOD-GROUP SYSTEM; MALE; MICE; MIDDLE AGED; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 0029925934     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0396-350     Document Type: Article

References (17)

1. Pastan, I. et al. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res. 51, 3781-3187 (1991).
2. Pai, L.H. & Pastan, I. Immunotoxin therapy for cancer. JAMA 269, 78 (1993).
3. Pai, L.H. & Pastan, I. Monoclonal antibodies in cancer therapy: Immunotoxins and recombinant toxins, in Biologic Therapy of Cancer 2nd edn. (eds DeVita, V.T., Hellman, S. & Rosenberg, S.A.) 521-533 (Lippincott, Philadelphia, 1995).
4. Vitetta, E.S. et al. Phase I immunotoxin trial in patients with B cell lymphoma. Cancer Res. 51, 4052-4058 (1991).
5. French, R.R., Hamblin, T.J., Bell, A.J., Tutt, A.L. & Glennie, M. Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin. Lancet 346, 223-224 (1995).
6. Gould, B.J. et al. Phase I study of an anti-breast cancer immunotoxin by continuous infusion: Report of a target toxic effect not predicted by animal studies. J. Natl. Cancer Inst. 81, 775-781 (1989).
7. Allured, V.S. et al. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom. Proc. Natl. Acad. Sci. USA 83, 1320-1324 (1986).
8. Hwang, J., FitzGerald, D.J., Adhya, S. & Pastan, I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48, 129-136 (1987).
9. Kondo, T., FitzGerald, D., Chaudhary, V.K., Adhya, S. & Pastan, I. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J. Biol. Chem. 263, 9470-9475 (1988).
10. Pastan, I.H., Pai, L.H., Brinkmann, U. & FitzGerald, D.J. Recombinant toxins: New therapeutic agents for cancer. Ann. N.Y. Acad. Sci. 758, 345-354 (1995).
11. Y damage human endothelial cells in an antibody specific mode: Relevance to vascular leak syndrome. Clin. Cancer Res. (in the press).
12. Roscoe, D.M. et al. Primate antibody response to immunotoxins: Serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin. Infect. Immun. 62, 5055-5065 (1994).
13. Wang, Q.-c., Pai, L.H., Debinski, W., FitzGerald, D.J. & Pastan, I. Preparation of polyethylene glycol modified forms of TGFα-PE40 that are cytotoxic and have a markedly prolonged survival in the circulation of mice. Cancer Res. 53, 4588-4594 (1993).
14. Yoshimoto, T. et al. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. 77, 1264-1270 (1986).
15. Jain, R.K. & Baxter, L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure. Cancer Res. 48, 7022-7032 (1988).
16. Brinkmann, U., Pai, L.H., FitzGerald, D.J., Willingham, M.C. & Pastan, I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA 88, 8616-8620 (1991).
17. Willingham, M. Immunohistochemical methods: Useful and informative tools for screening of hybridomas in the evaluation of antigen expression. Focus 12, 62-67 (1990).